InternationalUSRemember you can easily switch between MIP US and MIP International at any time

New Zealand: Patents Act 2013 now in force




New Zealand's new Patents Act 2013 came into force on September 13 2014. The changes in the new Act were intended to align New Zealand's patent laws more closely with those of other countries including major trading partners.

The Patents Act 2013 is the first major overhaul of New Zealand's patent system in 60 years. As the majority of applications filed at the Intellectual Property Office of New Zealand (IPONZ) are national phase entries into New Zealand, few of the changes will cause difficulties for applicants long used to stricter requirements in other jurisdictions. However, a five year restriction on filing divisional applications is causing some consternation.

The other significant changes include tougher examination of patent applications, stricter deadlines, subject matter exclusions, more challenge options and annual renewal fees.

  • Applications will be published 18 months from the earliest priority date, rather than on acceptance as under the 1953 Act.
  • Examination is no longer automatic. You must request examination within five years of filing or two months of receiving a direction, whichever is earlier, and pay an examination fee.
  • Applications will now be examined for inventive step, not just novelty. The prior art base, against which both novelty and inventive step will be tested, encompasses all matter and information available anywhere before the priority date.
  • Applications must be in order for acceptance within one year of a first examination report issuing. The applicant must respond to the examination report within six months, and to any further exam reports within three months, all subject to the one year prosecution deadline.
  • Divisional applications can only be filed within five years of the filing date of the application to which they are antedated. Examination must also be requested within this period.
  • Conflicting applications are considered using the whole contents approach, replacing the more limited prior claiming standard.
  • The new Act will prevent or make it more difficult for software inventions to be patented. Methods of treatment and diagnostic methods are also not patentable.
  • As well as retaining pre-grant opposition and post-grant revocation, the new Act introduces new ways to challenge patents and applications in the form of pre-acceptance third-party observations and pre- and post-grant re-examination.
  • Annual renewal fees will be due to keep an application pending or a granted patent in force under the new Act, compared to four payments under the old Act. A pre-grant maintenance fee is also payable, beginning on the fourth anniversary of the filing date.

The changes brought in by the new Act have necessitated a complete overhaul of IPONZ's electronic filing and file management system which may take some time to bed down.

IPONZ has indicated that applications will be examined within about three months of a request for examination being made. Unless you wish to be one of the first to road test the new legislation, we suggest you wait for a direction to issue before requesting examination.

Jo Shaw

AJ Park
Level 22, State Insurance Tower
1 Willis Street, Wellington 6011
New Zealand
Tel: +64 4 473 8278
Fax: +64 4 472 3358
wellington@ajpark.com
www.ajpark.com


Comments






profile

Managing IP

ManagingIP

ManagingIP profile

Federal Circuit’s Brunetti ruling: barring immoral or scandalous marks is unconstitutional restriction of free spee… https://t.co/MivCKFINHg

Dec 15 2017 10:12 ·  reply ·  retweet ·  favourite
ManagingIP profile

Federal Circuit rules in Amgen v Sandoz on remand from SCOTUS https://t.co/uYIkfVhCHG https://t.co/2OZAscsz32

Dec 14 2017 09:58 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @mdloney: Canada moves closer to joining the Hague Agreement with the release of proposed new Industrial Design Regulations https://t.co

Dec 12 2017 10:22 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

End of Year 2017

Tribal sovereign immunity: Taking a wrecking ball to the IPR system

The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe says others are “lining up to do deals”. But, Michael Loney asks, will the PTAB rule that sovereign immunity applies in these types of deals?



Most read articles

Supplements